Alma Bio Therapeutics presented in the biotech session of the special webinar “Bouncing back from the crisis. How to re-establish partnerships between Israel and the Auvergne Rhône-Alpes region”.
January 2021 – Alma Bio Therapeutics attended the 4th Antigen Specific Immune Tolerance digital event.
September 2020 - Prof. Francisco Javier Quintana of Brigham and Women’s Hospital Harvard Medical School, a world-renowned expert in immune regulation and tolerance, joins Alma’s scientific advisory board.
July 2020 - Alma Bio Therapeutics was among the recipients of PGE, the French government state guaranteed loan.
March 2020 - Alma Bio Therapeutics participated at Digital BioEurope Spring
March 2020 - Alma Bio Theraeutics presented at the RESI Digital partnering event